IFP Advisors, Inc - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 41 filers reported holding INMUNE BIO INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2023$1,246
-60.3%
184
-50.0%
0.00%
Q2 2023$3,141
+113.7%
368
+100.0%
0.00%
Q1 2023$1,470
+73400.0%
184
-50.0%
0.00%
Q4 2022$2
-99.8%
368
+100.0%
0.00%
Q3 2022$1,0000.0%1840.0%0.00%
Q2 2022$1,000
-50.0%
184
-50.0%
0.00%
Q1 2022$2,0000.0%368
+100.0%
0.00%
Q4 2021$2,000
-66.7%
184
-35.2%
0.00%
Q3 2021$6,000
+100.0%
284
+54.3%
0.00%
Q2 2021$3,000
+50.0%
1840.0%0.00%
Q1 2021$2,0001840.00%
Other shareholders
INMUNE BIO INC shareholders Q2 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 230,500$2,351,0001.70%
Fermata Advisors, LLC 17,955$183,0000.07%
Virtu Financial LLC 24,364$249,0000.02%
YorkBridge Wealth Partners, LLC 10,369$106,0000.02%
Jump Financial, LLC 21,100$215,0000.01%
Financial Advocates Investment Management 15,167$155,0000.01%
FNY Investment Advisers, LLC 1,100$11,0000.01%
Janney Montgomery Scott LLC 113,914$1,162,0000.01%
Walleye Capital LLC 17,127$175,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 12,473$127,0000.00%
View complete list of INMUNE BIO INC shareholders